Accelerated follicle depletion in vitro and in vivo in sprague-dawley rats using the combination of 4-vinylcyclohexene diepoxide and triptolide

Journal of Zoo and Wildlife Medicine

Volumn 44, Issue 4 SUPPL, 2013, Pages

  Dyer, Cheryl A ^a   Raymond Whish, Stefanie ^a   Schmuki, Shawn ^a   Fisher, Theresa ^a   Pyzyna, Brandy ^a   Bennett, Aaron ^a   Mayer, Loretta P ^a  

^a SenesTech Inc   (United States)

Author keywords

4 Vinylcyclohexene diepoxide; ovarian follicles; Sprague Dawley rats; triptolide

Indexed keywords

4 VINYL 1 CYCLOHEXENE DIOXIDE; 4-VINYL-1-CYCLOHEXENE DIOXIDE; CONTRACEPTIVE AGENT; CYCLOHEXENE DERIVATIVE; DITERPENE; EPOXIDE; PHENANTHRENE DERIVATIVE; TRIPTOLIDE; VINYL DERIVATIVE;

ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; OVARY FOLLICLE; POPULATION DYNAMICS; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CONTRACEPTIVE AGENTS, FEMALE; CYCLOHEXENES; DITERPENES; EPOXY COMPOUNDS; FEMALE; OVARIAN FOLLICLE; PHENANTHRENES; POPULATION CONTROL; RATS; RATS, SPRAGUE-DAWLEY; VINYL COMPOUNDS;

EID: 84892748091     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/1042-7260-44.4S.S9     Document Type: Article

References (15)

1. Christensen, T. K., P. Lassen, and M. Elmeros. 2012. High exposure rates of anticoagulant rodenticides in predatory bird species in intensively managed landscapes in Denmark. Arch. Environ. Contam. Toxicol. 63:437-444.
2. Chugh, R., V. Sangwan, S. P. Patil, V. Dudeja, S. B. Dawra, R. J. Schumacher, B. R. Blazar, G. I. Georg, S. M. Vickers, and A. K. Saluja. 2012. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer. Sci. Transl. Med. 4(156):156ra139.
3. Devine, P. J., I. G. Sipes, M. K. Skinner, and P. B. Hoyer. 2002. Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinylcyclohexene diepoxide. Toxicol. Appl. Pharmacol. 184:107-115.
4. Easterbrook, J.D., T. Shields, S. L. Klein, andG. E. Glass. 2005. Norway rat population in Baltimore, Maryland, 2004. Vector Borne Zoonotic Dis. 5:296-299.
5. Gao, Y., and R. V. Short. 1993. The control of rodent populations. Oxf. Rev. Reprod. Biol. 15:265-310.
6. Hinds, L. A., T. T. Tran, and A. K. Blome. 2012. Effect of different periods of treatment with 4-vinylcyclohexene diepoxide (VCD) on fertility of female rats. 7th International Conference on Fertility Control for Wildlife. (Abstr.) 1,4 pg. 12.
7. Keiner, C. 2005. Wartime rat control, rodent ecology and the rise and fall of chemical rodenticides. Endeavour 29:119-125.
8. Liu, J., Z. Jiang, L. Liu, Y. Zhang, S. Zhang, J. Xiao, M. Ma, and L. Zhang. 2011. Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats. Drug Chem. Toxicol. 34:1-7.
9. Mark-Kappeler, C. J., N. Sen, A. Lukefahr, L. McKee, I. G. Sipes, J. Konhilas, and P. B. Hoyer. 2011. Inhibition of ovarian KIT phosphorylation by the ovotoxicant 4-vinylcyclohexene diepoxide in rats. Biol. Reprod. 85:755-762.
10. Mayer, L. P., N. A. Pearsall, P. J. Christian, P. J. Devine, C.M. Payne,M. K. McCuskey, S. L. Marion, I. G. Sipes, and P. B. Hoyer. 2002. Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod. Toxicol. 16:775-781.
11. Titov, D. V., B. Gilman, Q. L. He, S. Bhat, W. K. Low, Y. Dang, M. Smeaton, A. L. Demain, P. S. Miller, J. F. Kugel, J. A. Goodrich, and J. O. Liu. 2011. XPB, a subunit of TRIIH, is a target of the natural product triptolide. Nat. Chem. Biol. 7:182-188.
12. U.S. Environmental Protection Agency. 2008. Final risk mitigation decision for ten rodenticides. www.epa.gov/oppsrrd1/reregistration/rodenticides/ finalriskdecision.htm. Accessed June 2013.
13. U.S. Environmental Protection Agency. 2013. Cancellation process for 12 D-Con mouse and rat poison products. www.epa.gov/pesticides/mice-and-rats/ cancellation-process.html. Accessed June 2013.
14. Wade, G. N., J. E. Schneider, and H. Y. Li. 1996. Control of fertility by metabolic cues. Am. J. Physiol. 270:E1-19.
15. Xu, C., and Y. Zhao. 2010. Apoptosis of rat's ovarian follicle cells induced by triptolide in vivo. Afr. J. Pharm. Pharmacol. 4:422-430.